Petrolatum Jelly Recalled Due to Temperature Exposure Prior to Delivery
Petrolatum jelly products are being recalled because facility temperature excursions from June through August 2021 may have reduced product effectiveness. The FDA states this specific storage deviation is not likely to cause adverse health consequences.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses or injuries. The FDA explicitly states that adverse health consequences are not likely from this specific storage deviation. The hazard is theoretical—temperature exposure may have reduced product effectiveness—but no actual harm has been reported.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Dynarex petrolatum jelly products distributed nationwide. The recall includes WeCare Petrolatum Jelly (5-gram packets, Catalog #1140) and Dynarex Petroleum Jelly (4-ounce tubes, Catalog #1145). All lots received between June 1, 2021, and September 30, 2021, are affected by this recall.
The recall is due to facility temperature excursions that occurred from June 2021 through August 2021 before the products were delivered. Exposure to higher than appropriate temperatures may have reduced product effectiveness.
According to the FDA, this device with the specific storage temperature deviation is not likely to cause adverse health consequences. Consumers should contact McKesson Medical-Surgical Inc. with questions or to arrange returns of affected products.
The recalled product
- Product
- a. DYNAREX WeCare PETROLATUM JELLY, WHT 5GM (144/BX 6BX/CS) DYNREX Catalog #1140. b. DYNAREX Dynarex PETROLEUM JELLY, WHITE 4OZ TU(72/CS) DYNREX Catalog #1145
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Medical Device
- Hazard
- temperature-exposure
- reduced-efficacy
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- not available
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03
- SevereAbiomed Automated Impella Controller recalled for motor control and pump failure risks
FDA (Devices) · 2026-06-03
- HighGE APEXPRO and CARESCAPE Telemetry Systems Risk Loss of Patient Monitoring
FDA (Devices) · 2026-06-03
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03